News Scientists issue call to arms over antifungal resistance Infectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to antifungal drugs.
News Novo-backed $61m fundraising helps F2G prep for antifungal l... Anglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening fungal infections through late-stage development and onto
Partner Content Partner Content Combating Antifungal Resistance to be discussed at Superbugs... Antifungal Resistance at Superbugs & Superdrugs 2019
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.